Relying on Guardant Reveal for continued health

Retired engineer Keith Davies shares his journey from routine blood test to beating prostate cancer. Early detection is key.

Renowned biotech entrepreneur Professor Sir Chris Evans leads a £3 million raise for EDX Medical, boosting its cutting-edge prostate cancer test.

Learn about Councillor Jacob Allen’s March the Month challenge for Prostate Cancer Awareness Month, raising awareness and funds to fight this silent killer.

Discover the groundbreaking new prostate cancer detection test by EDX Medical Group, set to revolutionize early diagnosis for improved treatment outcomes.

Discover the revolutionary AI-powered prostate cancer screening test developed in Cambridge. EDX Medical Group is leading the way in personalised treatment solutions.

Discover EDX Medical’s revolutionary non-invasive prostate cancer diagnostic, utilising AI and multi-omics technology for unparalleled accuracy and personalized treatment strategies.

Discover the latest advancements in prostate cancer testing revolutionising early diagnosis and screening, offering hope for improved patient outcomes.

Discover the groundbreaking prostate cancer test from Cambridge’s EDX Medical Group, offering precise detection and personalised treatment options.

Colin Egglesfield faces cancer for the third time, inspiring others to prioritise their health. Learn about his journey and advocacy efforts here.

Early cancer detection is key to improving outcomes for men. Dr Donald Babu stresses the importance of recognizing warning signs to safeguard health.

Guardant Health secures Medicare coverage for Guardant Reveal test, enhancing CRC monitoring. Analysts predict revenue growth and improved patient outcomes.

Guardant Health partners with Adicon to revolutionise cancer research in China, offering advanced liquid biopsy and genomic profiling solutions for clinical trials.

Coronation Street’s Kevin Webster faces testicular cancer in a powerful storyline. Actor Michael Le Vell takes viewers on an emotional journey of resilience and relationships.

Discover how genetic testing can empower you to take control of your health by understanding your inherited cancer risks and taking proactive measures with NHS-supported tests.

Testicular cancer is rare but can be life-threatening. Early detection is key, especially for young men between 15 and 35. Awareness saves lives.

Guardant Health and Boehringer Ingelheim are revolutionizing cancer care with Guardant360 CDx liquid biopsy, potentially transforming NSCLC treatment.

Discover how EDX Medical Group Plc (AQSE:EDX) is revolutionising digital clinical diagnostics to predict disease risk and personalise healthcare.